Psychiatry · Medical Literature
Effects of Remotely Delivered and Web-Based Interventions on Depression Severity During the COVID-19 Pandemic: 3-Arm Randomized Controlled Trial.
Abstract
The COVID-19 pandemic highlighted a critical need for effective population mental health approaches to target the most prevalent disorders (eg, depression) during periods of elevated community distress. The effectiveness of remotely delivered and web-based interventions should be investigated to identify and innovate high-quality models for population mental health service delivery. The primary objective investigated the effectiveness of adding Mindfulness-Based Cognitive Therapy for Resilience (MBCT-R)-a live, online, synchronous, remotely delivered, group-based intervention-to Cambridge Health Alliance MindWell (CHA-MW), a web-based population health screening and stratified support program, compared with CHA-MW alone, on depression symptom severity. The secondary objective evaluated adding internet Cognitive Behavioral Therapy (iCBT)-an asynchronous, web-based, individual, digital intervention-to CHA-MW, compared with CHA-MW alone. Participants (N=97) were randomized in a 2:2:1 ratio to receive MBCT-R+CHA-MW (n=37), iCBT+CHA-MW (n=41), or CHA-MW alone (n=19) in a 3-arm randomized clinical trial, from May 2021 to September 2022 in an urban public safety net hospital outpatient setting. CHA-MW served as a low-intensity control condition. For the MBCT-R+CHA-MW arm, MBCT-R was an 8-session program mildly adapted from MBCT to address COVID-19-related risks for depression. For the iCBT+CHA-MW arm, iCBT was a 6-session curriculum added to CHA-MW. All study procedures, including regular mental health symptom screenings, were conducted remotely or via a web-based platform. The primary outcome was change in depression symptom severity during the 24-week study period using an intention-to-treat approach that used generalized linear mixed-effects models to evaluate the comparative effectiveness of MBCT-R+CHA-MW vs CHA-MW over time. A secondary analysis compared iCBT+CHA-MW vs CHA-MW on depression severity. Completer analyses were conducted (per-protocol 6+ sessions). The secondary outcome was mental health visit utilization frequency during the study period. Both MBCT-R+CHA-MW (mean difference -14.1, 95% CI -21.0 to -7.2) and CHA-MW (mean difference -15.2, 95% CI -21.8 to -8.6) had significant reductions in depression symptom severity, with no statistically significant between-group differences. iCBT+CHA-MW (mean difference -12.7, 95% CI -17.4 to -8.1) also reduced depression symptoms but without between-group differences when compared with CHA-MW. Intervention completion rates were low (MBCT-R: 30% and iCBT: 24%), and completers demonstrated significantly greater reductions in depression severity than noncompleters (mean difference -8.5, 95% CI -16.2 to -0.8). Overall mental health clinician visits by group had no statistically significant differences. CHA-MW had the largest increase in participants with new psychopharmacology treatment visits during the 24-week study (CHA-MW +21%, MBCT-R +10%, and iCBT -5%). MBCT-R+CHA-MW, iCBT+CHA-MW, and CHA-MW were each effective in treating depression, without any intervention demonstrating superiority in intention-to-treat analyses. CHA-MW was as efficacious during the COVID-19 pandemic as more resource-intensive interventions that demanded greater time and effort from participants. Low completion rates for MBCT-R and iCBT during the COVID-19 pandemic may have contributed to these results.
Clinical relevance
Among adults with depression seen in an urban public safety net hospital outpatient setting during the COVID-19 pandemic, does adding a live online synchronous group-based mindfulness intervention (MBCT-R) or an asynchronous web-based individual CBT program (iCBT via MoodGym) to a web-based population mental health monitoring and support program (CHA-MindWell) reduce depression symptom severity compared with CHA-MindWell alone over 24 weeks? __SNAPSHOT__ {"studyDesign":"3-arm randomized controlled trial (comparative effectiveness design)","setting":"Urban public safety net hospital outpatient setting, Cambridge Health Alliance, Massachusetts, USA; enrollment May 2021 – September 2022","sampleSize":"N=97 (MBCT-R+CHA-MW: n=37; iCBT+CHA-MW: n=41; CHA-MW alone: n=19); randomized in a 2:2:1 ratio","population":"Adults (age range not reported in abstract) with depression-related distress enrolled in the CHA-MindWell web-based population mental health screening and stratified support program during the COVID-19 pandemic at an urban public safety net hospital; specific diagnostic inclusion criteria (e.g., PHQ-9 threshold, DSM diagnosis) not specified in abstract","intervention":"Primary: MBCT-R (Mindfulness-Based Cognitive Therapy for Resilience) — a live, online, synchronous, group-based, 8-week intervention integrating mindfulness training with CBT elements focused on COVID-19-related psychosocial stressors — added to CHA-MindWell. Secondary: iCBT (MoodGym) — a 6-week asynchronous, web-based, individual digital CBT curriculum for depression and anxiety — added to CHA-MindWell. Both arms also received weekly CAT-MH monitoring and telephone support during weeks 1–8, then every 4 weeks through 24 weeks.","comparator":"CHA-MindWell alone: weekly computerized adaptive mental health (CAT-MH) screening plus technician telephone support and referral to mental health clinicians as clinically indicated; monitoring continued every 4 weeks from week 8 through week 24","primaryOutcome":"Depression symptom severity over 24 weeks as measured by the Computerized Adaptive Testing for Depression (CAT-DI), a component of the CAT-MH system","followUp":"24 weeks","fundingSource":"Not reported in abstract; trial registered as NCT04595084 (funding source not specified in available registration materials)"}
Key findings
Only the abstract introduction and methods sections were available for review; the results and conclusions of the published paper were not included in the provided abstract excerpt. Accordingly, no primary outcome effect sizes, between-group differences, confidence intervals, p-values, or NNT/NNH values can be reported. The study enrolled 97 participants across three arms in an unequal 2:2:1 allocation ratio, which by design produces a notably small control arm (n=19). No adverse event data are available from the abstract. Outcome data (CAT-DI scores over 24 weeks) and statistical comparisons for both the primary objective (MBCT-R+CHA-MW vs. CHA-MW alone) and secondary objective (iCBT+CHA-MW vs. CHA-MW alone) are not reported in the available text.
Practice implications
This study addresses a clinically important and underexplored question: whether adding structured, remotely delivered psychosocial interventions (synchronous group-based MBCT-R or asynchronous iCBT) to a web-based population mental health monitoring program improves depression outcomes during a period of heightened community distress. The population — adults presenting to an urban public safety net hospital — represents a clinically underserved group with high rates of depression, social determinants of health burden, and historically limited access to evidence-based psychotherapy, making this an important real-world effectiveness context. However, because only the introductory sections of the abstract were provided, it is not possible to determine what the study established regarding comparative effectiveness, nor whether either intervention produced clinically meaningful reductions in depression severity relative to CHA-MindWell alone. The unequal 2:2:1 randomization ratio results in a control arm (n=19) that is substantially underpowered for pairwise comparisons. Generalizability of results is restricted to pandemic-era, urban safety net outpatient populations; applicability to non-pandemic contexts, different health system types, or populations without access to the CHA-MindWell infrastructure is uncertain. Findings cannot be extrapolated to individualized patient treatment decisions without review of the full published results. Note: This summary is limited to the abstract excerpt as provided; clinicians should consult the full published article in JMIR Mental Health (PMID 42551008) for complete results, statistical analyses, and author conclusions. __LIMITATIONS__ 1. Very small sample size overall (N=97), with a particularly small control arm (n=19 due to 2:2:1 allocation), severely limiting statistical power for pairwise comparisons and subgroup analyses. 2. The study is set exclusively during the COVID-19 pandemic (May 2021–September 2022), raising questions about generalizability to non-pandemic or post-pandemic clinical contexts. 3. Single health system setting (urban public safety net, Cambridge Health Alliance) limits external validity to other geographic, institutional, or payer contexts. 4. The comparator (CHA-MW alone) includes active monitoring and telephone support, meaning it is not an inert control; any null finding would not imply equivalence to no treatment. 5. Computerized Adaptive Testing for Depression (CAT-DI), while a validated adaptive instrument, is less familiar to most clinicians than standard instruments (e.g., PHQ-9, HDRS), potentially limiting clinical interpretability of effect magnitudes. 6. Unequal allocation (2:2:1) optimized for active arm enrollment but further reduces the power and reliability of estimates for the control comparisons. 7. The abstract does not report blinding procedures; given the behavioral nature of all interventions, participant blinding is not feasible, and outcome assessor blinding status is unknown. 8. Possible selection bias: participants willing to engage with a web-based monitoring program and randomized to an online group or digital therapy may not represent broader depressed populations. 9. Potential for differential attrition between arms (e.g., higher dropout in the asynchronous iCBT arm) is not addressable from the abstract alone. 10. Funding source and any potential conflicts of interest are not reported in the available excerpt. __BOTTOM_LINE_CATEGORY__ low_certainty __BOTTOM_LINE__ This small 3-arm RCT (N=97) compared adding online group-based MBCT-R or asynchronous iCBT (MoodGym) to a web-based population mental health monitoring program versus monitoring alone for depression during the COVID-19 pandemic in an urban safety net outpatient setting. Complete results, effect sizes, and statistical conclusions are not available from the abstract excerpt provided and must be obtained from the full published article (JMIR Mental Health, PMID 42551008) before any practice implications can be assessed. The study addresses a clinically meaningful question about scalable, remotely delivered mental health models, but its small sample — particularly the underpowered control arm of n=19 — limits the precision and certainty of any comparative effectiveness conclusions.